BioregulatorResearch
Bronchogen
Also known as: Ala-Glu-Asp-Leu · AEDL
A tetrapeptide bioregulator for bronchial function, prescribed for COPD, asthma, and post-viral lung scarring.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Activates bronchial epithelial gene expression to rebuild damaged airways and restore local immune defenses.
Key Research Areas
bioregulatorbronchialCOPDasthma
Frequently Asked Questions
What is Bronchogen?▾
A tetrapeptide bioregulator for bronchial function, prescribed for COPD, asthma, and post-viral lung scarring.
How does Bronchogen work?▾
Activates bronchial epithelial gene expression to rebuild damaged airways and restore local immune defenses.
What is the recommended dosage for Bronchogen?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Bronchogen?▾
The half-life of Bronchogen is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Bronchogen FDA approved?▾
Bronchogen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Bronchogen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.